Endoluminal therapy for GERD: Is the evidence for efficacy any stronger?
Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Lee, Thomas J. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2007 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Springer 2007 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Current GERD reports - Philadelphia, Pa. : Current Science Inc., 2007, 1(2007), 1 vom: März, Seite 50-55 |
|---|---|
| Übergeordnetes Werk: |
volume:1 ; year:2007 ; number:1 ; month:03 ; pages:50-55 |
| Links: |
|---|
| DOI / URN: |
10.1007/s12171-007-0034-9 |
|---|
| Katalog-ID: |
SPR025398695 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR025398695 | ||
| 003 | DE-627 | ||
| 005 | 20230519110255.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s2007 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12171-007-0034-9 |2 doi | |
| 035 | |a (DE-627)SPR025398695 | ||
| 035 | |a (SPR)s12171-007-0034-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lee, Thomas J. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Springer 2007 | ||
| 520 | |a Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. | ||
| 650 | 4 | |a Lower Esophageal Sphincter |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Lower Esophageal Sphincter Pressure |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Esophageal Acid Exposure |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Acid Exposure Time |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Gastric Plication |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Kahrilas, Peter J. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current GERD reports |d Philadelphia, Pa. : Current Science Inc., 2007 |g 1(2007), 1 vom: März, Seite 50-55 |w (DE-627)564751030 |w (DE-600)2422347-5 |x 1934-9661 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:2007 |g number:1 |g month:03 |g pages:50-55 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s12171-007-0034-9 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2190 | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 2007 |e 1 |c 03 |h 50-55 | ||
| author_variant |
t j l tj tjl p j k pj pjk |
|---|---|
| matchkey_str |
article:19349661:2007----::nouiateayogritevdneoef |
| hierarchy_sort_str |
2007 |
| publishDate |
2007 |
| allfields |
10.1007/s12171-007-0034-9 doi (DE-627)SPR025398695 (SPR)s12171-007-0034-9-e DE-627 ger DE-627 rakwb eng Lee, Thomas J. verfasserin aut Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Springer 2007 Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. Lower Esophageal Sphincter (dpeaa)DE-He213 Lower Esophageal Sphincter Pressure (dpeaa)DE-He213 Esophageal Acid Exposure (dpeaa)DE-He213 Acid Exposure Time (dpeaa)DE-He213 Gastric Plication (dpeaa)DE-He213 Kahrilas, Peter J. aut Enthalten in Current GERD reports Philadelphia, Pa. : Current Science Inc., 2007 1(2007), 1 vom: März, Seite 50-55 (DE-627)564751030 (DE-600)2422347-5 1934-9661 nnns volume:1 year:2007 number:1 month:03 pages:50-55 https://dx.doi.org/10.1007/s12171-007-0034-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_702 GBV_ILN_2190 AR 1 2007 1 03 50-55 |
| spelling |
10.1007/s12171-007-0034-9 doi (DE-627)SPR025398695 (SPR)s12171-007-0034-9-e DE-627 ger DE-627 rakwb eng Lee, Thomas J. verfasserin aut Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Springer 2007 Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. Lower Esophageal Sphincter (dpeaa)DE-He213 Lower Esophageal Sphincter Pressure (dpeaa)DE-He213 Esophageal Acid Exposure (dpeaa)DE-He213 Acid Exposure Time (dpeaa)DE-He213 Gastric Plication (dpeaa)DE-He213 Kahrilas, Peter J. aut Enthalten in Current GERD reports Philadelphia, Pa. : Current Science Inc., 2007 1(2007), 1 vom: März, Seite 50-55 (DE-627)564751030 (DE-600)2422347-5 1934-9661 nnns volume:1 year:2007 number:1 month:03 pages:50-55 https://dx.doi.org/10.1007/s12171-007-0034-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_702 GBV_ILN_2190 AR 1 2007 1 03 50-55 |
| allfields_unstemmed |
10.1007/s12171-007-0034-9 doi (DE-627)SPR025398695 (SPR)s12171-007-0034-9-e DE-627 ger DE-627 rakwb eng Lee, Thomas J. verfasserin aut Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Springer 2007 Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. Lower Esophageal Sphincter (dpeaa)DE-He213 Lower Esophageal Sphincter Pressure (dpeaa)DE-He213 Esophageal Acid Exposure (dpeaa)DE-He213 Acid Exposure Time (dpeaa)DE-He213 Gastric Plication (dpeaa)DE-He213 Kahrilas, Peter J. aut Enthalten in Current GERD reports Philadelphia, Pa. : Current Science Inc., 2007 1(2007), 1 vom: März, Seite 50-55 (DE-627)564751030 (DE-600)2422347-5 1934-9661 nnns volume:1 year:2007 number:1 month:03 pages:50-55 https://dx.doi.org/10.1007/s12171-007-0034-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_702 GBV_ILN_2190 AR 1 2007 1 03 50-55 |
| allfieldsGer |
10.1007/s12171-007-0034-9 doi (DE-627)SPR025398695 (SPR)s12171-007-0034-9-e DE-627 ger DE-627 rakwb eng Lee, Thomas J. verfasserin aut Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Springer 2007 Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. Lower Esophageal Sphincter (dpeaa)DE-He213 Lower Esophageal Sphincter Pressure (dpeaa)DE-He213 Esophageal Acid Exposure (dpeaa)DE-He213 Acid Exposure Time (dpeaa)DE-He213 Gastric Plication (dpeaa)DE-He213 Kahrilas, Peter J. aut Enthalten in Current GERD reports Philadelphia, Pa. : Current Science Inc., 2007 1(2007), 1 vom: März, Seite 50-55 (DE-627)564751030 (DE-600)2422347-5 1934-9661 nnns volume:1 year:2007 number:1 month:03 pages:50-55 https://dx.doi.org/10.1007/s12171-007-0034-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_702 GBV_ILN_2190 AR 1 2007 1 03 50-55 |
| allfieldsSound |
10.1007/s12171-007-0034-9 doi (DE-627)SPR025398695 (SPR)s12171-007-0034-9-e DE-627 ger DE-627 rakwb eng Lee, Thomas J. verfasserin aut Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? 2007 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Springer 2007 Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. Lower Esophageal Sphincter (dpeaa)DE-He213 Lower Esophageal Sphincter Pressure (dpeaa)DE-He213 Esophageal Acid Exposure (dpeaa)DE-He213 Acid Exposure Time (dpeaa)DE-He213 Gastric Plication (dpeaa)DE-He213 Kahrilas, Peter J. aut Enthalten in Current GERD reports Philadelphia, Pa. : Current Science Inc., 2007 1(2007), 1 vom: März, Seite 50-55 (DE-627)564751030 (DE-600)2422347-5 1934-9661 nnns volume:1 year:2007 number:1 month:03 pages:50-55 https://dx.doi.org/10.1007/s12171-007-0034-9 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_702 GBV_ILN_2190 AR 1 2007 1 03 50-55 |
| language |
English |
| source |
Enthalten in Current GERD reports 1(2007), 1 vom: März, Seite 50-55 volume:1 year:2007 number:1 month:03 pages:50-55 |
| sourceStr |
Enthalten in Current GERD reports 1(2007), 1 vom: März, Seite 50-55 volume:1 year:2007 number:1 month:03 pages:50-55 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Lower Esophageal Sphincter Lower Esophageal Sphincter Pressure Esophageal Acid Exposure Acid Exposure Time Gastric Plication |
| isfreeaccess_bool |
false |
| container_title |
Current GERD reports |
| authorswithroles_txt_mv |
Lee, Thomas J. @@aut@@ Kahrilas, Peter J. @@aut@@ |
| publishDateDaySort_date |
2007-03-01T00:00:00Z |
| hierarchy_top_id |
564751030 |
| id |
SPR025398695 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR025398695</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519110255.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2007 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12171-007-0034-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR025398695</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12171-007-0034-9-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lee, Thomas J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Endoluminal therapy for GERD: Is the evidence for efficacy any stronger?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Springer 2007</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lower Esophageal Sphincter</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lower Esophageal Sphincter Pressure</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Esophageal Acid Exposure</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acid Exposure Time</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastric Plication</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kahrilas, Peter J.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current GERD reports</subfield><subfield code="d">Philadelphia, Pa. : Current Science Inc., 2007</subfield><subfield code="g">1(2007), 1 vom: März, Seite 50-55</subfield><subfield code="w">(DE-627)564751030</subfield><subfield code="w">(DE-600)2422347-5</subfield><subfield code="x">1934-9661</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:50-55</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12171-007-0034-9</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2007</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">50-55</subfield></datafield></record></collection>
|
| author |
Lee, Thomas J. |
| spellingShingle |
Lee, Thomas J. misc Lower Esophageal Sphincter misc Lower Esophageal Sphincter Pressure misc Esophageal Acid Exposure misc Acid Exposure Time misc Gastric Plication Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? |
| authorStr |
Lee, Thomas J. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)564751030 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1934-9661 |
| topic_title |
Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? Lower Esophageal Sphincter (dpeaa)DE-He213 Lower Esophageal Sphincter Pressure (dpeaa)DE-He213 Esophageal Acid Exposure (dpeaa)DE-He213 Acid Exposure Time (dpeaa)DE-He213 Gastric Plication (dpeaa)DE-He213 |
| topic |
misc Lower Esophageal Sphincter misc Lower Esophageal Sphincter Pressure misc Esophageal Acid Exposure misc Acid Exposure Time misc Gastric Plication |
| topic_unstemmed |
misc Lower Esophageal Sphincter misc Lower Esophageal Sphincter Pressure misc Esophageal Acid Exposure misc Acid Exposure Time misc Gastric Plication |
| topic_browse |
misc Lower Esophageal Sphincter misc Lower Esophageal Sphincter Pressure misc Esophageal Acid Exposure misc Acid Exposure Time misc Gastric Plication |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Current GERD reports |
| hierarchy_parent_id |
564751030 |
| hierarchy_top_title |
Current GERD reports |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)564751030 (DE-600)2422347-5 |
| title |
Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? |
| ctrlnum |
(DE-627)SPR025398695 (SPR)s12171-007-0034-9-e |
| title_full |
Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? |
| author_sort |
Lee, Thomas J. |
| journal |
Current GERD reports |
| journalStr |
Current GERD reports |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2007 |
| contenttype_str_mv |
txt |
| container_start_page |
50 |
| author_browse |
Lee, Thomas J. Kahrilas, Peter J. |
| container_volume |
1 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Lee, Thomas J. |
| doi_str_mv |
10.1007/s12171-007-0034-9 |
| title_sort |
endoluminal therapy for gerd: is the evidence for efficacy any stronger? |
| title_auth |
Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? |
| abstract |
Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. © Springer 2007 |
| abstractGer |
Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. © Springer 2007 |
| abstract_unstemmed |
Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments. © Springer 2007 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_702 GBV_ILN_2190 |
| container_issue |
1 |
| title_short |
Endoluminal therapy for GERD: Is the evidence for efficacy any stronger? |
| url |
https://dx.doi.org/10.1007/s12171-007-0034-9 |
| remote_bool |
true |
| author2 |
Kahrilas, Peter J. |
| author2Str |
Kahrilas, Peter J. |
| ppnlink |
564751030 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s12171-007-0034-9 |
| up_date |
2024-07-03T15:46:07.218Z |
| _version_ |
1803573334872424448 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR025398695</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519110255.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2007 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s12171-007-0034-9</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR025398695</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s12171-007-0034-9-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lee, Thomas J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Endoluminal therapy for GERD: Is the evidence for efficacy any stronger?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2007</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Springer 2007</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Gastroesophageal reflux disease is a common disorder often requiring long-term treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered the US and European markets, claiming effectiveness comparable to that of antireflux surgery. Despite these claims, there has been a paucity of data to support that efficacy, even as more devices are coming onto the market. This review examines reports of endoluminal reflux therapies published between January 2004 and December 2006. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lower Esophageal Sphincter</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lower Esophageal Sphincter Pressure</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Esophageal Acid Exposure</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acid Exposure Time</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gastric Plication</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kahrilas, Peter J.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Current GERD reports</subfield><subfield code="d">Philadelphia, Pa. : Current Science Inc., 2007</subfield><subfield code="g">1(2007), 1 vom: März, Seite 50-55</subfield><subfield code="w">(DE-627)564751030</subfield><subfield code="w">(DE-600)2422347-5</subfield><subfield code="x">1934-9661</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2007</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:50-55</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s12171-007-0034-9</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2007</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">50-55</subfield></datafield></record></collection>
|
| score |
7.400546 |